Market cap
$375,849 Mln
Revenue (TTM)
$66,400 Mln
P/E Ratio
122.9
P/B Ratio
8.8
Div. Yield
2.2 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 1.97 | 5.11 | 4.24 | 4.43 | 7.87 |
| EBIT | 95.53 | -102.98 | -64.72 | 4.01 | 2.97 |
| Net Profit | 68.54 | -130.12 | -80.62 | 4.80 | -8.39 |
| EPS | 68.51 | -130.66 | -80.70 | 1.01 | -10.62 |
| Book Value | -- | -- | 16.01 | 5.42 | 16.23 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| 24.21 | 26.43 | 10.86 | 34.54 | 33.05 |
| Net Margin
| -- | 25.60 | 4.78 | -- | -- |
| Return on equity
| 26.20 | 30.84 | 6.72 | 36.91 | 40.81 |
| Return on Capital
| 13.85 | 16.13 | -- | 19.45 | 21.61 |
| Return on Assets
| 10.00 | 11.35 | 2.11 | 14.37 | 15.30 |
| Debt to Equity (x)
| -- | -- | 1.22 | 0.96 | 0.83 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
--
|
19.45
|
21.61
|
0.48
|
19.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
6.72
Lower than Peers by 12.25
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
6.72
|
36.91
|
40.81
|
0.87
|
34.50
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
ROA
2.11
Lower than Peers by 0.75
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
2.11
|
14.37
|
15.30
|
0.34
|
13.52
|
|
Peer Median
|
2.86
|
--
|
--
|
--
|
--
|
EBIT Margin
10.86
Lower than Peers by 4.96
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
10.86
|
34.54
|
33.05
|
5.05
|
29.36
|
|
Peer Median
|
15.82
|
--
|
--
|
--
|
--
|
Net Margin
4.78
Lower than Peers by 3.45
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
4.78
|
28.12
|
26.68
|
0.61
|
25.13
|
|
Peer Median
|
8.23
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
4.24
Lower than Peers by 3.81
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
4.24
|
0.01
|
0.07
|
0.01
|
0.22
|
|
Peer Median
|
8.05
|
--
|
--
|
--
|
--
|
EBIT Growth
-64.72
Lower than Peers by 72.98
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
-64.72
|
5.74
|
598.75
|
-82.56
|
18.53
|
|
Peer Median
|
8.26
|
--
|
--
|
--
|
--
|
Net Profit Growth
-80.62
Lower than Peers by 88.35
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
-80.62
|
6.64
|
4,589.59
|
-97.49
|
11.27
|
|
Peer Median
|
7.73
|
--
|
--
|
--
|
--
|
EPS Growth
-80.70
Lower than Peers by 91.09
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
-80.70
|
0.09
|
46.14
|
-0.97
|
0.11
|
|
Peer Median
|
10.39
|
--
|
--
|
--
|
--
|
Book Value Growth
-12.99
Lower than Peers by 17.87
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
-12.99
|
--
|
--
|
--
|
--
|
|
Peer Median
|
4.87
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.22
Higher than Peers by 0.62
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
1.22
|
0.96
|
0.83
|
0.97
|
0.70
|
|
Peer Median
|
0.59
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.07
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
0.07
|
0.05
|
0.06
|
0.04
|
0.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.32
Lower than Peers by 0.33
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
1.32
|
1.54
|
1.36
|
1.25
|
1.47
|
|
Peer Median
|
1.65
|
--
|
--
|
--
|
--
|
Quick Ratio
1.10
Lower than Peers by 0.10
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
1.10
|
1.30
|
1.15
|
1.00
|
1.23
|
|
Peer Median
|
1.20
|
--
|
--
|
--
|
--
|
Interest Coverage
4.41
Lower than Peers by 0.35
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
4.41
|
16.52
|
16.69
|
2.65
|
18.09
|
|
Peer Median
|
4.77
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
18.92
Lower than Peers by 2.35
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
18.92
|
19.53
|
16.02
|
17.22
|
15.94
|
|
Peer Median
|
21.27
|
--
|
--
|
--
|
--
|
Asset Turnover
0.44
Higher than Peers by 0.04
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
0.44
|
0.51
|
0.57
|
0.56
|
0.55
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
--
|
64.57
|
58.71
|
60.15
|
57.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
--
|
128.14
|
149.86
|
138.94
|
124.44
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
--
|
85.14
|
96.17
|
92.71
|
93.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
--
|
107.57
|
112.39
|
106.39
|
88.92
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
122.85
Higher than Peers by 84.95
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
122.85
|
14.35
|
14.77
|
762.89
|
19.47
|
|
Peer Median
|
37.91
|
--
|
--
|
--
|
--
|
Price / Book Value
8.82
Higher than Peers by 1.13
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
8.82
|
4.98
|
5.46
|
7.41
|
6.15
|
|
Peer Median
|
7.69
|
--
|
--
|
--
|
--
|
Dividend Yield
2.19
Higher than Peers by 1.63
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
2.19
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.56
|
--
|
--
|
--
|
--
|
EV/EBITDA
28.91
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
28.91
|
10.54
|
10.79
|
44.54
|
14.14
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
375,849
Higher than Peers by 373,328
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Merck & Company Inc (MRK)
|
375,849
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2,521
|
--
|
--
|
--
|
--
|